On Wednesday, the European stock market rose again slightly, continuously making up for its losses from Monday. Yesterday morning, the markets feared that the sell-offs in the Chinese market could lead to major upheavals, which, however, remained unfounded. The Chinese stock markets have already recovered and are optimistic about the future due to the excellent progress in the AI sector. Yesterday, Wednesday, it was Banco Santander that was able to track the strongest movement in the index in the Euro Stoxx 50 with a premium of over 8 percent.
Outperformance on the British stock market
The FTSE 100 also experienced a positive Wednesday with the top 100 stocks from the UK. The index, which closed the day in the red on Tuesday, managed to turn positive on Wednesday. The FTSE 100 outperformed the most important European markets with a plus of 0.6 percent. At the top of the index was the share of Glaxo Smith Kline (GSK), which experienced a price premium of 7.6 percent. The share is still in the red for the year, but the business forecasts have convinced investors and investors. The FTSE 100 is once again on the verge of breaking out to a new all-time high. The index could also be helped by a Bank of England, which meets for an interest rate decision today, Thursday, if it softens its conservative course. In any case, the market expects an interest rate cut of 25 basis points.
British pound works on uptrend
The interest rate decision is also likely to have an impact on the British pound. The currency has stabilized to almost 1.25 US dollars in recent weeks since mid-January. Here, special attention is paid to the Trump administration, which is shooting around wildly with threats of punitive tariffs in order to enforce its interests with force. If, as expected, the UK does not expect any direct punitive tariffs, an impending trade war between the USA and China could also have a sensitive impact on the British pound.
The information provided does not constitute investment research. The material has not been prepared in accordance with the legal requirements designed to promote the independence of investment research and as such is to be considered to be a marketing communication.
All information has been prepared by ActivTrades (“AT”). The information does not contain a record of AT’s prices, or an offer of or solicitation for a transaction in any financial instrument. No representation or warranty is given as to the accuracy or completeness of this information.
Any material provided does not have regard to the specific investment objective and financial situation of any person who may receive it. Past performance is not a reliable indicator of future performance. AT provides an execution-only service. Consequently, any person acting on the information provided does so at their own risk.